Valuation

Valuation is more than a number, it’s a narrative backed by logic, evidence, and alignment. At Elm Innovation Advisors, we help early-stage and innovation-driven companies, and their investors, boards, bankers, and legal advisors, understand what a business is worth, and why.

In high-IP industries like life sciences, healthcare, technology, and data-driven businesses, valuation is rarely straightforward. There’s often limited revenue, uncertain timing, and significant upside—or downside—based on key strategic decisions. We bring structure to that uncertainty by combining robust modeling, market context, and scenario analysis to build valuations that are defensible, flexible, and relevant to the decisions at hand.

We support valuation work across a range of use cases, including:

• Fundraising and Capital Planning – aligning capital needs and valuation expectations with milestones and investor perspectives

• M&A and Partnering – supporting buy- and sell-side negotiations with clear valuation frameworks and comparables

• Board and Internal Planning – informing resource allocation, equity structuring, and strategic option value

• Licensing and IP Transactions – quantifying the value of intangible assets, pipelines, or platforms in early or ambiguous stages

• Disputes and Litigation Support – delivering valuation analyses that can withstand scrutiny in adversarial or expert contexts

Our work is designed to hold up in rooms where the stakes are high and the assumptions are challenged. We don’t inflate expectations or over-engineer complexity, we build grounded, transparent, and actionable valuations that support smarter decisions.